BioClec
Pioneering microglial therapies for Alzheimer's disease
Milan, Italy · Founded 2025
- Headquarters
- Milan
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- bioclec.com
- Last Round
- SeedMar 2025
- Rounds
- 1
About
BioClec is a Milan, Italy-based biotechnology company launched in March 2025, focused on developing pioneering therapies for Alzheimer's disease. Emerging from Sofinnova Partners' 165M euro Biovelocita II accelerator program, BioClec targets microglia — the brain's critical immune cell population — to develop disease-modifying interventions via a novel microglial pathway. The company was co-founded by Dr. Marco Colonna, a global expert in neuroimmunology and Professor of Pathology & Immunology at Washington University School of Medicine, and is led by CEO Gabriella Camboni.
Summary
BioClec is a Biotech company based in Milan, Italy, founded in 2025. Its most recent funding was a Seed round in Mar 2025. Investors include Sofinnova Partners.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2025
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bioclec"><img src="https://indexed.vc/api/badge/company/bioclec" alt="BioClec on Indexed.vc" width="260" height="76" /></a>